OncLive - Bringing the Oncology Community Together

A supplemental biologics license application has been submitted to the FDA for daratumumab in combination with bortezomib, thalidomide, and dexamethasone for the treatment of patients with newly diagnosed multiple myeloma... Read More >>

Emerging Treatments in Multiple Myeloma Spark Prospect for Cure

Childhood Cancer Survivors at Increased Risk for Skin Cancers

HER2+ Breast Cancer Paradigm Slated to Expand With Novel Therapies

Progress Continues in HR+/HER2- Breast Cancer Paradigm

CAR T Cells Bring Promise to Patients With ALL, DLBCL With Poor Prognosis

View More Stories >>

View Conference Coverage

2019 NCCN Annual Conference

2019 State of the Science Summit on Hematologic Malignancies

2019 SGO Annual Meeting

2019 AACR Annual Meeting

2019 Miami Breast Cancer Conference

Dr. Matulonis on Individualized Dosing of Niraparib in Ovarian Cancer

Dr. Higano on Role of PARP Inhibitors in Prostate Cancer

Dr. Hurvitz on Toxicity Associated With Neratinib in HER2+ Breast Cancer

Dr. Hunt on Treating Local Regional Recurrence in Breast Cancer

Dr. Ferguson on a Population-Based Study of Women Undergoing Radical Hysterectomy

Dr. Bardia on Sacituzumab Govitecan in TNBC

Dr. Perez-Soler on Improved Outlook for Patients With Lung Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

When to Use Inotuzumab Ozogamicin for Adult ALL

$Selecting a Novel Therapy for Relapsed/Refractory ALL$

Selecting a Novel Therapy for Relapsed/Refractory ALL

Allogeneic Transplant at First Remission of ALL

Establishing MRD's Role in ALL Management

Adjuvant Therapy for Early-Stage Colon Cancer

$Relapsed/Refractory mCRC: Treatment Dosing Strategies$

Choosing Therapy for Newly Diagnosed NonDriver NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Cardio-Oncology and Prostate Cancer

Waldenstrom Macroglobulinemia: Diagnostic Criteria

Waldenstrom Macroglobulinemia: Risk Factors

$Relapsed/Refractory Multiple Myeloma: Switching Therapy$

$Relapsed/Refractory Multiple Myeloma: Optimal Therapy$

The Future of Pancreatic Cancer Treatment

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>